CD8-based T cell vaccination and CD4 T cell responses in prostate cancer.
Alexander
Richard B
RB
Division of Urology, University of Maryland, School of Medicine, Baltimore, Maryland 21201, USA. ralexander@smail.umaryland.edu
D000917:Antibody Formation / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002999:Clone Cells / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology; D059811:HLA-DRB1 Chains; D006801:Humans; D016233:Immunotherapy, Active; D008297:Male; D017430:Prostate-Specific Antigen / Q000276:immunology; D011471:Prostatic Neoplasms / Q000276:immunology / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D022223:Vaccines, Subunit / Q000276:immunology*
D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D022223:Vaccines, Subunit; D017430:Prostate-Specific Antigen